Stock Events

Stock Events

Relmada Therapeutics (RLMD) Q2 2025 Earnings

12MayConfirmed

Q3 2024

Q4 2024

Q1 2025

Q2 2025

-0.83

-0.71

-0.6

-0.48

Details

Expected EPS

-0.48

Actual EPS

-0.58

Surprise EPS

-0.1

Surprise Percent

+20.83%

Description

Relmada Therapeutics (RLMD) has reported earnings of -0.58 per share for Q2 2025.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.